| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/24/2010 | EP2156842A1 Oral composition |
| 02/24/2010 | EP2155726A1 Phthalazinone derivatives and their use as medicament to treat cancer |
| 02/24/2010 | EP2155720A1 Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application |
| 02/24/2010 | EP2155718A2 Aryloxazole, aryloxadiazole and benzimidazole derivatives as modulators of somatostatine receptor activity |
| 02/24/2010 | EP2155704A1 Thiadiazole derivatives as antidiabetic agents |
| 02/24/2010 | EP2155695A1 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS |
| 02/24/2010 | EP2155220A1 Compositions for suppressing obesity |
| 02/24/2010 | EP2155198A2 Piperidine/piperazine derivatives |
| 02/24/2010 | EP2155187A1 Method of treatment using fused aromatic compounds having anti-diabetic activity |
| 02/24/2010 | EP2154998A2 Kit of nutritional compositions for infants with fat and carbohydrate content adapted to the particular stage of development |
| 02/24/2010 | EP2029596B1 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same |
| 02/24/2010 | EP1931335B1 Hexahydro cyclooctyl pyrazole cannabinoid modulators |
| 02/24/2010 | EP1863488B1 Use of amino-substituted 8-n-benzimidazoles |
| 02/24/2010 | EP1465631B1 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 02/24/2010 | CN101654479A Mammalian receptor proteins, agents, and methods relating thereto |
| 02/24/2010 | CN101653603A Peptides and antibodies binding to anionic phospholipids and aminophospholipids and their use in treating disease |
| 02/24/2010 | CN101653450A Improved dietary fiber containing materials comprising low molecular weight glucan |
| 02/24/2010 | CN101653421A Compositions comprising pectin and ascorbic acid |
| 02/24/2010 | CN100591320C Stable surfactant compositions for suspending components |
| 02/23/2010 | USRE41151 Comprising a modified NSAID, wherein the NSAID is covalently attached either directly or through a linker molecule to a sulfur-containing functional group containing an optionally substituted hydrocarbyl moiety; nonsteroidal anti-inflammatory drugs; side-effect reduction |
| 02/23/2010 | USRE41150 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors; compounds based on thieno(4,3,2-ef)(2)benzazepin-6-one |
| 02/23/2010 | US7667053 Cannabinoid-1 (CB1) receptor antagonists and/or inverse agonists; e.g. N-(2,3-bis(4-chlorophenyl)-1-methylpropyl)-1,4-benzodioxane-2-carboxamide; psychological disorders, eating disorders |
| 02/23/2010 | US7667008 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 02/23/2010 | US7666909 Enhancement of alcohol metabolism |
| 02/23/2010 | US7666900 ATP-binding cassette transport 1 (ABCA1) stabilizers; using probucol spiroquinone/probucol diphenoquinone as prophylactic/therapeutic agents to decrease ABCA1 expression; low-HDL (high-density lipoprotein) cholesterolemia; arteriosclerosis; pharmacogenetics |
| 02/23/2010 | US7666899 Administering mitglinide or mitglinide calcium hydrate; hypertriglyceridemia; hypercholesterolemia; hyperlipidemia; anticholesteraol agents; antidiabetic agents; glucose intolerance; non-insulin dependendent diabetes; side effect reduction; cardiovascular disorders |
| 02/23/2010 | US7666885 Enzyme inhibitors |
| 02/23/2010 | US7666869 Nitrogen-containing 5-membered ring compound |
| 02/23/2010 | US7666848 such as 3-(4-Methoxy-phenyl)-1-[3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-thiophen-2-yl]-propan-1-one; for use as antidiabetics |
| 02/23/2010 | US7666845 Compounds having inhibitory activity against sodium-dependent glucose transporter |
| 02/23/2010 | US7666839 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 02/23/2010 | US7666835 oxyntomodulin a polypeptide is administered to a obese mammal by oral, parenteral, mucosal, rectal subcutaneous or transdermal administration |
| 02/23/2010 | US7666832 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 02/23/2010 | US7666831 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 02/23/2010 | US7666830 Nutritional composition preventing bacterial overgrowth |
| 02/23/2010 | US7666657 Method for production of arachidonic acid |
| 02/23/2010 | US7666647 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease |
| 02/23/2010 | US7666405 Deleted adenovirus vectors and methods of making and administering the same |
| 02/23/2010 | US7666402 Use of IL-22 for the treatment of conditions of metabolic disorders |
| 02/23/2010 | US7666401 Compositions comprising a ligand of Chemerin R |
| 02/23/2010 | CA2548811C Drug and food or drink for improving hyperglycemia |
| 02/23/2010 | CA2462289C Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 02/23/2010 | CA2374102C Compositions containing creatine in suspension |
| 02/23/2010 | CA2329930C Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 02/23/2010 | CA2297115C Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 02/23/2010 | CA2232288C Treating niddm with rxr agonists |
| 02/18/2010 | WO2010019830A1 Glucagon antagonists |
| 02/18/2010 | WO2010019828A1 Glucagon receptor antagonists |
| 02/18/2010 | WO2010019606A1 Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators |
| 02/18/2010 | WO2010019435A2 Solid states of atorvastatin potassium |
| 02/18/2010 | WO2010019276A2 Method and formulation for treating adverse biological conditions |
| 02/18/2010 | WO2010018800A1 Acetyl pyrrolidinyl indole derivative |
| 02/18/2010 | WO2010018614A1 Hydrophilic amino acid-containing preparation having improved taste |
| 02/18/2010 | WO2010018547A1 Aminoquinoline compounds |
| 02/18/2010 | WO2010018435A1 Amide glycosides |
| 02/18/2010 | WO2010017598A1 Anti-il-12/il-23 antibodies |
| 02/18/2010 | WO2010017570A2 Pharmaceutical form comprising tetrahydrobiopterin |
| 02/18/2010 | WO2009127398A3 Conjugated linoleic acid derivatives |
| 02/18/2010 | WO2009120801A3 Ikki inhibitor therapies and screening methods, and related ikki diagnostics |
| 02/18/2010 | WO2008121006A8 Selenium administration |
| 02/18/2010 | US20100041768 Composition and method of adipose cell differentiation inhibition |
| 02/18/2010 | US20100041764 Therapeutic agent for diabetic neuropathy |
| 02/18/2010 | US20100041755 Fatty acid treatment for cardiac patients |
| 02/18/2010 | US20100041751 Method to Reduce Oxidative Damage and Improve Mitochondrial Efficiency |
| 02/18/2010 | US20100041736 Isolated MCPIP and Methods of Use |
| 02/18/2010 | US20100041735 Modulation of toll-like receptor 3 expression by antisense oligonucleotides |
| 02/18/2010 | US20100041721 Selective androgen receptor modulators |
| 02/18/2010 | US20100041717 N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
| 02/18/2010 | US20100041711 Urea Glucokinase Activators |
| 02/18/2010 | US20100041709 Substituted n-(4-cyano-1h-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof |
| 02/18/2010 | US20100041705 Organic Compounds |
| 02/18/2010 | US20100041695 Thieno[2,3-b]pyridines as Potassium Channel Inhibitors |
| 02/18/2010 | US20100041679 Oral dieting composition comprising conjugated linoleic acid and caffeine |
| 02/18/2010 | US20100041660 Novel 2-pyridinecarboxamide derivatives |
| 02/18/2010 | US20100041657 Haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
| 02/18/2010 | US20100041651 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 02/18/2010 | US20100041650 Purine compounds as cannabinoid receptor blockers |
| 02/18/2010 | US20100041612 Fragments of the Glucagon-Like Peptide-1 and Uses Thereof |
| 02/18/2010 | US20100041590 Compounds |
| 02/18/2010 | US20100041151 Compositions and methods for treating lysosomal storage disease |
| 02/18/2010 | US20100040704 Composition and method for weight reduction |
| 02/18/2010 | US20100040682 Fenofibrate tablets |
| 02/18/2010 | US20100040621 Novel polpeptide and use thereof |
| 02/18/2010 | US20100040604 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 02/18/2010 | US20100040537 antibodies that are wild-type, chimeric, CDR grafted and humanized; disease or disorder in which prostaglandin E2 activity is detrimental, such as cancer, atuoimmune diseases, inflammatory diseases |
| 02/18/2010 | CA2770298A1 Glucagon antagonists |
| 02/18/2010 | CA2733966A1 Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators |
| 02/18/2010 | CA2733646A1 Acetyl pyrrolidinyl indole derivative |
| 02/18/2010 | CA2733642A1 Anti-il-12/il-23 antibodies |
| 02/17/2010 | EP2154131A1 G protein-coupled receptor inhibitor and pharmaceutical product |
| 02/17/2010 | EP2153831A1 Anti-fatigue agent and oral composition each comprising andrographolide as active ingredient |
| 02/17/2010 | EP2152719A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 02/17/2010 | EP2152710A2 4,4-disubstituted piperidine derivatives |
| 02/17/2010 | EP2152707A1 [6,5]-bicyclic gpr119 g protein-coupled receptor agonists |
| 02/17/2010 | EP2152701A1 Phenyl amino pyrimidine compounds and uses thereof |
| 02/17/2010 | EP2152671A1 Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders |
| 02/17/2010 | EP2152294A2 Methods of modulating cellular homeostatic pathways and cellular survival |
| 02/17/2010 | EP2152284A1 A synergistic ayurvedic / functional food bioactive composition [cincata] |
| 02/17/2010 | EP2152276A1 Screening assay to identify correctors of protein trafficking defects |
| 02/17/2010 | EP2152271A1 Piperidine/piperazine derivatives |